Genomic Characterization of Dengue Virus Outbreak in 2022 from Pakistan
Vaccines · 11.01.2023 · 11 (1) · 163
DOI: 10.3390/vaccines11010163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 11.01.2023. Verfasst von Massab Umair und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, National Institute of Health, Islamabad 45500, Pakistan. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pakistan, a dengue-endemic country, has encountered several outbreaks during the past decade. The current study aimed to explore the serotype and genomic diversity of dengue virus responsible for the 2022 outbreak in Pakistan. From August to October 2022, NS-1 positive blood samples (n = 343) were collected from dengue patients, among which, (85%; n = 293) were positive based on RT-PCR. In terms of gender and age, dengue infection was more prevalent in male patients (63%; n = 184), with more adults (21–30 years; n = 94) being infected. The serotyping results revealed DENV-2 to be the most predominant serotype (62%; n = 183), followed by DENV-1 (37%; n = 109) and DENV-3 (0.32%; n = 1). Moreover, a total of 10 samples (DENV-2; n = 8, DENV-1; n = 2) were subjected to whole-genome sequencing. Among these, four were collected in early 2022, and six were collected between August and October 2022. Phylogenetic analysis of DENV-2 sequenced samples (n = 8) revealed a monophyletic clade of cosmopolitan genotype IVA, which is closely related to sequences from China and Singapore 2018, and DENV-1 samples (n = 2) show genotype III, which is closely related to Pakistan isolates from 2019. We also reported the first whole genome sequence of a coinfection case (DENV1-DENV2) in Pakistan detected through a meta-genome approach. Thus, dengue virus dynamics reported in the current study warrant large-scale genomic surveillance to better respond to future outbreaks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Virology, National Institute of Health, Islamabad 45500, Pakistan.
ORCID-Profile: Massab Umair, Shaheen Bibi, Aamer Ikram
Zitieren
APA
Umair, M., Haider, S. A., Rehman, Z., Jamal, Z., Ali, Q., Hakim, R., Bibi, S., Ikram, A., & Salman, M. (2023). Genomic Characterization of Dengue Virus Outbreak in 2022 from Pakistan. Vaccines, 11(1), 163. https://doi.org/10.3390/vaccines11010163
Vancouver
Umair M, Haider SA, Rehman Z, Jamal Z, Ali Q, Hakim R, et al. Genomic Characterization of Dengue Virus Outbreak in 2022 from Pakistan. Vaccines. 2023;11(1):163. doi:10.3390/vaccines11010163
BibTeX
@article{Umair2023,
author = {Umair, Massab and Haider, Syed Adnan and Rehman, Zaira and Jamal, Zunera and Ali, Qasim and Hakim, Rabia and Bibi, Shaheen and Ikram, Aamer and Salman, Muhammad},
title = {Genomic Characterization of Dengue Virus Outbreak in 2022 from Pakistan},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {1},
pages = {163},
doi = {10.3390/vaccines11010163}
}
EUVIMED